Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2008 1
2009 1
2010 1
2011 2
2012 2
2013 1
2014 1
2015 3
2016 3
2017 2
2018 1
2019 9
2020 10
2021 7
2022 9
2023 13
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu JJ, Henson JW, Engelhard HH, Chen TC, Tran DD, Sroubek J, Tran ND, Hottinger AF, Landolfi J, Desai R, Caroli M, Kew Y, Honnorat J, Idbaih A, Kirson ED, Weinberg U, Palti Y, Hegi ME, Ram Z. Stupp R, et al. Among authors: sroubek j. JAMA. 2015 Dec 15;314(23):2535-43. doi: 10.1001/jama.2015.16669. JAMA. 2015. PMID: 26670971 Free article. Clinical Trial.
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH; ACT IV trial investigators. Weller M, et al. Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23. Lancet Oncol. 2017. PMID: 28844499 Free article. Clinical Trial.
Wearable cardiac monitors: Where do we stand?
Sroubek J. Sroubek J. Cleve Clin J Med. 2024 Jan 2;91(1):31-32. doi: 10.3949/ccjm.91a.23081. Cleve Clin J Med. 2024. PMID: 38167401 Free article. No abstract available.
Same-day discharge after atrial fibrillation ablation.
Aguilera J, Hutt E, Madden R, Kanj M, Saliba W, Rickard J, Sroubek J, Callahan T, Chung M, Baranowski B, Martin D, Dresing T, Wazni OM, Hussein A, Cantillon D, Patel D, Nakhla S, Taigen T. Aguilera J, et al. Among authors: sroubek j. Heliyon. 2023 Nov 10;9(11):e22178. doi: 10.1016/j.heliyon.2023.e22178. eCollection 2023 Nov. Heliyon. 2023. PMID: 38045193 Free PMC article.
Ischemic or Coronary Evaluations in Patients With Monomorphic VT Electrical Storm Undergoing VT Ablation.
Alkhalaileh F, Wazni OM, Kiang A, Parker J, Ellis S, Kanj M, Farwati M, Menon V, Callahan T, Baranowski B, Nakhla S, Taigen T, Santangeli P, Kewan T, Cantillon D, Sroubek J, Rickard J, Zmaili M, Bhargava M, Saliba WI, Nakagawa H, Hussein AA. Alkhalaileh F, et al. Among authors: sroubek j. JACC Clin Electrophysiol. 2023 Sep;9(9):1890-1899. doi: 10.1016/j.jacep.2023.04.030. Epub 2023 Aug 2. JACC Clin Electrophysiol. 2023. PMID: 37542488
65 results